• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Arch Virol . Isolation, identification and whole genome sequence analysis of influenza B virus from Shanghai during 2023-2024

tetano

Editor, Senior Moderator
Arch Virol

. 2026 Nov 8;171(12):317.
doi: 10.1007/s00705-026-06754-7.

Isolation, identification and whole genome sequence analysis of influenza B virus from Shanghai during 2023-2024​


Muhammad Awais Ashraf # 1 2 , Lihuan Yue # 1 , Muhammad Asif Raza 1 2 , Bei Shen 1 , Huiting Xu 3 , Muhammad Nabeel Amjad 1 2 , Ghayyas Ud Din 1 2 , Lingdie Chen 1 2 , Rongrong Hu 4 , Yuan Tian 4 , Ahsan Ali Bhutto 1 2 , Aguang Dai 5 , Huajie Yan 6 , Yihong Hu 7 8

Affiliations Expand


Abstract​


Influenza B virus, a member of the Orthomyxoviridae family, is a significant contributor to global respiratory infections alongside influenza A virus. This study investigated the prevalence and genomic characteristics of influenza B virus during the 2023-2024 season in Shanghai, China. Among 174 clinical samples collected from the Nanxiang Branch of Ruijin Hospital, the positivity rate for influenza B virus was 62.36%. Genomic analysis revealed that all characterized isolates belonged to the B/Victoria lineage and were classified within subclade C.5.7, corresponding to the legacy designation V1A.3a.2. No B/Yamagata lineage strains were detected. Comparative genomic analysis further revealed close genetic similarity between the Shanghai isolates and strains from Shanxi Province, suggesting a potential geographical or evolutionary relationship. These findings highlight the substantial activity of influenza B virus in Shanghai during the study period and underscore the importance of continued genomic surveillance to monitor viral evolution and inform public health strategies.
 
Back
Top Bottom